house · trading 2015-04-06 → 2019-05-02
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2019-05-02 | WAB | BUY | $1K–$15K | $74.98 | $292.23 2026-08-28 | +289.7% |
| 2019-04-26 | GSK | BUY | $1K–$15K | $40.40 | $50.82 2026-08-28 | +25.8% |
| 2016-09-06 | ABBV | SELL | $1K–$15K | $64.61 | $255.48 2026-08-28 | -295.4% exit |
| 2016-01-06 | ABBV | SELL | $1K–$15K | $57.38 | $255.48 2026-08-28 | -345.2% exit |
| 2015-04-06 | ABBV | SELL | $1K–$15K | $57.61 | $255.48 2026-08-28 | -343.5% exit |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Thomas H Tuberville | 3 · ABBV, GSK, WAB |
| Rohit Khanna | 3 · ABBV, GSK, WAB |
| James B. Renacci | 2 · ABBV, GSK |
| Thomas R Carper | 2 · ABBV, GSK |
| Virginia Foxx | 2 · ABBV, GSK |
| John Boozman | 2 · ABBV, GSK |
| K. Michael Conaway | 2 · ABBV, GSK |
| Kurt Schrader | 2 · ABBV, GSK |
| Alan Armstrong | 2 · ABBV, WAB |
| David P. Roe | 2 · ABBV, GSK |
| Kenny Marchant | 2 · ABBV, GSK |
| RICHARD M BURR | 2 · ABBV, GSK |